in this model blm and pep are carcinogenic : treatments resulted in significant dose-related incidences of animals with tumors at the site of application ( fibrosarcomas ) and with renal tumors ( adenomas , adenocarcinomas , sarcomas ) .
C0005740
blm
C1261473
sarcomas